Wnt3a Facilitates SARS-CoV-2 Pseudovirus Entry into Cells

Int J Mol Sci. 2023 Dec 22;25(1):217. doi: 10.3390/ijms25010217.

Abstract

How ACE2 functions as the major host receptor of SARS-CoV-2 despite having low expression in the lungs is still unknown. To facilitate the development of therapeutic strategies against coronaviruses, gaining a deeper comprehension of the molecular mechanism of SARS-CoV-2 infection is imperative. In our previous study, we identified several potential host factors of SARS-CoV-2 using an shRNA arrayed screen, one of which was Wnt3a. Here, we validated the significance of Wnt3a, a potent activator of the Wnt/β-catenin signaling pathway, for SARS-CoV-2 entry into cells by evaluating the effects of its knockdown and overexpression on SARS-CoV-2 pseudotyped virus entry. Further analysis revealed that SARS-CoV-2 pseudotyped virus infection activates the canonical Wnt/β-catenin signaling pathway, which we found could subsequently stimulate ACE2 transcription. Collectively, our study identified Wnt3a as an important host factor that facilitates ACE2-mediated virus infection. Insight into the virus entry mechanism is impactful as it will aid in developing novel therapeutic strategies against current and future coronavirus pandemics.

Keywords: ACE2; SARS-CoV-2; Wnt3a; canonical pathway; host factor; virus entry; β-catenin.

MeSH terms

  • Angiotensin-Converting Enzyme 2 / genetics
  • COVID-19*
  • Humans
  • Pandemics
  • RNA, Small Interfering
  • SARS-CoV-2*

Substances

  • Angiotensin-Converting Enzyme 2
  • RNA, Small Interfering